294 related articles for article (PubMed ID: 10360262)
1. Telomerase activity in complete hydatidiform mole.
Sukcharoen N; Mutirangura A; Limpongsanurak S
J Reprod Med; 1999 May; 44(5):465-70. PubMed ID: 10360262
[TBL] [Abstract][Full Text] [Related]
2. Measurement of CA-125 in trophoblastic disease.
Kohorn EI
Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
[TBL] [Abstract][Full Text] [Related]
3. Preevacuation serum CA 125 in complete hydatidiform mole.
Tangtrakul S; Srisupandit S; Chailurkit LO; Rajatanavin R
Gynecol Oncol; 1997 Mar; 64(3):487-9. PubMed ID: 9062156
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity in complete hydatidiform mole.
Bae SN; Kim SJ
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):328-33. PubMed ID: 9988795
[TBL] [Abstract][Full Text] [Related]
5. Complete hydatidiform mole and a coexistent viable fetus: report of two cases and review of the literature.
Bruchim I; Kidron D; Amiel A; Altaras M; Fejgin MD
Gynecol Oncol; 2000 Apr; 77(1):197-202. PubMed ID: 10739712
[TBL] [Abstract][Full Text] [Related]
6. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
[TBL] [Abstract][Full Text] [Related]
7. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
8. Natural history of twin pregnancy with complete hydatidiform mole and coexisting fetus.
Steller MA; Genest DR; Bernstein MR; Lage JM; Goldstein DP; Berkowitz RS
Obstet Gynecol; 1994 Jan; 83(1):35-42. PubMed ID: 8272304
[TBL] [Abstract][Full Text] [Related]
9. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
Niemann I; Hansen ES; Sunde L
Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
[TBL] [Abstract][Full Text] [Related]
10. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
[TBL] [Abstract][Full Text] [Related]
11. Repetitive complete and partial hydatidiform mole.
Rice LW; Lage JM; Berkowitz RS; Goldstein DP; Bernstein MR
Obstet Gynecol; 1989 Aug; 74(2):217-9. PubMed ID: 2748058
[TBL] [Abstract][Full Text] [Related]
12. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
13. Expression of human telomerase reverse transcriptase, the catalytic subunit of telomerase, is associated with the development of persistent disease in complete hydatidiform moles.
Amezcua CA; Bahador A; Naidu YM; Felix JC
Am J Obstet Gynecol; 2001 Jun; 184(7):1441-6. PubMed ID: 11408866
[TBL] [Abstract][Full Text] [Related]
14. A clinicopathologic study of 153 cases of complete hydatidiform mole (1980-1990): histologic grade lacks prognostic significance.
Genest DR; Laborde O; Berkowitz RS; Goldstein DP; Bernstein MR; Lage J
Obstet Gynecol; 1991 Sep; 78(3 Pt 1):402-9. PubMed ID: 1876374
[TBL] [Abstract][Full Text] [Related]
15. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
Shaarawy M; el-Shobokshy AS; el-Noury AI
Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
[TBL] [Abstract][Full Text] [Related]
16. Predictors of persistent disease in women with complete hydatidiform mole.
Ayhan A; Tuncer ZS; Halilzade H; Küçükali T
J Reprod Med; 1996 Aug; 41(8):591-4. PubMed ID: 8866387
[TBL] [Abstract][Full Text] [Related]
17. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
Berkowitz R; Ozturk M; Goldstein D; Bernstein M; Hill L; Wands JR
Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
[TBL] [Abstract][Full Text] [Related]
18. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
Kohorn EI; Kacinski BM; Stanley ER
Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
[TBL] [Abstract][Full Text] [Related]
20. Differences in current clinical features of diploid and triploid hydatidiform mole.
Niemann I; Petersen LK; Hansen ES; Sunde L
BJOG; 2007 Oct; 114(10):1273-7. PubMed ID: 17655732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
